Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Dongxin Pharmaceutical is a comprehensive pharmaceutical enterprise based in Wuhan, China, specializing in the research, development, production, and marketing of chemical drugs and Traditional Chinese Medicines. The company is a market leader in women's and children's health, particularly known for its extensive portfolio of gynecological topical formulations such as vaginal gels and suppositories. Dongxin operates modern, GMP-certified manufacturing facilities and maintains a robust distribution network across the Chinese domestic market. Their product range also extends into pediatrics, dermatology, and gastroenterology, offering both prescription and over-the-counter solutions. The company is recognized as a key high-tech enterprise in Hubei Province, focusing on the integration of traditional medical wisdom with modern pharmaceutical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Dongxin Pharmaceutical.